EASL clinical practice guidelines: Management of chronic hepatitis B virus infection - Wikidata - wikimedia - TriplyDB

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

http://www.wikidata.org/entity/Q29615868

about

Interferon for people with lamivudine-resistant chronic hepatitis B virus infection Pharmacological treatments for acute hepatitis B infection: a network meta-analysis Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection Antiviral agents for hepatitis B virus-related cirrhosis Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)Management of HBV and HBV/HDV-Associated Liver Cirrhosis Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention Strategies Prevention of Hepatitis B reactivation in the setting of immunosuppression KASL clinical practice guidelines: management of chronic hepatitis B Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Prophylactic managements of hepatitis B viral infection in liver transplantation Overview of hepatitis B virus mutations and their implications in the management of infection Liver transplantation for viral hepatitis in 2015 Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma Update on hepatitis B and C virus diagnosis The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis The Role of Oxidative Stress and Antioxidants in Liver Diseases MicroRNAs as Important Players in Host-hepatitis B Virus Interactions The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs Update on Alcohol and Viral Hepatitis Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection Update on Hepatitis B Virus Infection: Focus on Treatment Hepatitis B and Hepatitis C Reactivation in the Biologic Era Anti-HBV Drugs: Progress, Unmet Needs, and New Hope Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Prediction of fibrosis progression in chronic viral hepatitis Monoclonal antibody therapy and renal transplantation: focus on adverse effects Clinical applications of transient elastography Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends Management of patients with hepatitis B who require immunosuppressive therapy

P2860

Q24185973-7E0B3FA3-D07B-4ED9-A855-259DA085B754 Q24186837-870F5A54-BD3C-4B26-AF4F-3258C65BD05E Q24186878-B9403A5D-A27A-4E52-8E95-CFC322AD442E Q24187530-6642AEE5-D840-4D98-85A7-95616737468B Q24200681-B0920E7B-C7F2-4795-9E6A-AC7DA73452DD Q26740161-8075A446-C4E2-4EB2-AC8E-8C128D83B227 Q26740195-2DC5FA90-A61B-415F-A18E-411664381223 Q26740313-F1425E7A-650F-4F01-97D3-D0434E56B60C Q26740319-88C1E789-8247-455C-8BB0-D867939A0EA3 Q26740323-33832926-486D-4ED5-945B-BFDB1FF7C990 Q26746486-83DA6B37-A161-40E1-A747-02DAC78DC806 Q26747023-80A22658-797A-4E0E-B568-692E184E9AAE Q26752475-279A2361-50FE-4347-800A-2F30A539F750 Q26752690-0B288A40-03E4-46F7-9397-3410B294F13C Q26765290-AF04572F-0236-4731-A3DE-4B367B34AB2C Q26772036-F8ADCC42-C63A-4EC2-A680-5DC35084DB49 Q26772324-E3FCD238-6B90-48F4-A817-AEA21FF83A32 Q26772340-3191F560-665C-4AA7-9A6D-D6626E6E05FD Q26772346-EB7E25E3-1405-4342-9376-E2703DC61D63 Q26773224-FD1577C1-1D83-4F87-8FBC-6F9A7509FC0B Q26773251-5D825411-C926-4832-B9C4-3A3381170253 Q26777048-F4045F90-3293-41D3-8044-AA0263649B54 Q26778278-B8229FEA-4FC9-44C8-850E-68038BA2BF94 Q26779146-4818D481-05C1-4524-918F-B22C651FED1C Q26781737-BBDBE4A7-15D8-491D-B998-54E41FB10A32 Q26781795-D897CB38-AAE8-4263-9D4D-15A49D3B5695 Q26781897-538C55C6-680A-4C1D-9804-8A974E41D28E Q26781962-E528D936-20E3-4D99-9162-78ADBFBF6D09 Q26781990-6279A792-181B-4449-B405-ED571B447688 Q26781993-3D8FC787-0FB2-4858-BB9C-91C68D43D591 Q26782742-01406E92-BB88-47B5-AA13-E4D813916AA2 Q26784241-64CF08D1-5917-47A0-A22C-C38253866361 Q26796488-26817972-F125-4B5C-8522-8040674C3B01 Q26799933-98073214-FA6F-44B8-9E00-F882AB325230 Q26801716-F604523F-9A0D-4412-9003-E0BB1AACB5A1 Q26823671-31407B27-EE8A-4C7D-A5FA-1BBBA0E8D4B0 Q26826880-824527FE-C8D1-4AA7-8DB3-14411B81322B Q26828052-0DBCCAED-E315-4899-8916-A5BCBB821636 Q26830194-5D75EEC8-6FEB-474C-8CE2-7A348D4F31E6 Q26853490-E20A9858-DDA4-4EE9-913F-D2E8799DD93E

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

http://www.wikidata.org/entity/Q29615868

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@ast

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@en

type

label

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@ast

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@en

prefLabel

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@ast

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@en

P1433

Q29615868-277F1A98-A55F-4EF4-B9EC-83A3E6293564

P1476

Q29615868-1075BF74-DF2B-478D-8AA9-6723D080ED0C

P304

Q29615868-F0EE7671-F1C3-43E2-9E65-CC044FC7ED3F

P31

Q29615868-0562ECC4-5A33-4500-90D5-EB14C8C4C456

P3181

Q29615868-F5B14045-B746-4722-8249-82B87F892D54

P356

Q29615868-7F867D80-DB5A-45A0-A3FF-6608BC9F29C9

P407

Q29615868-4FDD8359-429D-430C-AB9B-73C734C06804

P433

Q29615868-CA467D89-3D43-4083-832F-F27805BB0B8A

P478

Q29615868-A4873D3A-DC6C-404F-98D2-D11BA8D3A3B9

P577

Q29615868-C42BCA4A-EE01-4031-AEDE-0B52C29A47A3

P5875

Q29615868-97C0C34B-2D68-4F9B-BFE5-A46741891230

P698

Q29615868-0F10DB12-0CF9-4D77-86C4-D6E0D87B05C6

P3181

P356

J.JHEP.2012.02.010

P1433

Journal of Hepatology

P1476

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

@en

P304

167-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

125612

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JHEP.2012.02.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221903446

http://www.w3.org/2001/XMLSchema#string

P698

22436845

http://www.w3.org/2001/XMLSchema#string